Sr One Capital Management, LP Portfolio Holdings
Sr One Capital Management, LP
- $228 Million
- Q2 2024
Sr One Capital Management, LP has filed its 13F form on August 13, 2024 for Q2 2024 where it was disclosed a total value porftolio of $228 Million distributed in 9 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Arcellx, Inc. with a value of $130M, Crispr Therapeutics Ag with a value of $56.7M, Design Therapeutics, Inc. with a value of $21.9M, Nkarta, Inc. with a value of $19.7M, and Alumis Inc. with a value of $0.
Examining the 13F form we can see an decrease of $69.3M in the current position value, from $297M to 228M.
Below you can find more details about Sr One Capital Management, LP portfolio as well as his latest detailed transactions.